BackenGene Holdings Overview

enGene Holdings Research & Development

Research & Development expenses for ENGN.

Quarterly R&D Expenses

$22.20M
↑ 9.83% YoY

As of Apr 30, 2026

Annual R&D Expenses (TTM)

$98.75M
↑ 56.73% YoY

Trailing 12 months ending Apr 30, 2026

Average R&D Expenses (Comparison Companies)

Research & Development History

Research & Development Comparison

Annual Research & Development Growth Rate (%)

Annual Research & Development Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin